Collectively, we have uncovered a molecular subset of PCa defined by a co-deletion of CIC and ERF and further demonstrate a mechanism-based strategy to potentially limit tumor progression through ETV1 inhibition in this subset of human PCa. This evidence concerns the gene ERF and neoplasm.